Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher M. Starr currently holds 21,973 shares of Monopar Therapeutics (MNPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher M. Starr has been a net seller of MNPR stock. They have purchased $0 and sold $7.4M worth of shares.
Christopher M. Starr's most recent insider trade was on Jul 14, 2025, when they sold 16,800 shares at $0.01 per share.
Christopher M. Starr serves as Executive at Monopar Therapeutics (MNPR). They have executed 108 insider transactions totaling $7.4M over their tenure at the company.
Christopher M. Starr holds the position of Executive at Monopar Therapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Christopher M. Starr has shown a selling trading pattern, with $0 in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher M. Starr was on Oct 24, 2016, when they sold $6.4M worth of RPTP shares. This transaction involved 706,065 shares at $9.00 per share.
Christopher M. Starr currently owns 21,973 shares of Monopar Therapeutics (MNPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher M. Starr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher M. Starr has 108 Form 4 filings on record as an insider at Monopar Therapeutics.
Set alerts for Christopher M. Starr and 40,000+ other insiders.